Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 161

1.

Microcalcification detection in full-field digital mammograms: A fully automated computer-aided system.

Basile TMA, Fanizzi A, Losurdo L, Bellotti R, Bottigli U, Dentamaro R, Didonna V, Fausto A, Massafra R, Moschetta M, Tamborra P, Tangaro S, La Forgia D.

Phys Med. 2019 Aug;64:1-9. doi: 10.1016/j.ejmp.2019.05.022. Epub 2019 Jun 14.

PMID:
31515007
2.

Invasive apocrine carcinoma of the breast: Myth or fact?

Gurrado A, Girardi A, Moschetta M, Serio G, Marzullo A, Telegrafo M, Fragassi F, Ferraro V, Testini M.

Breast J. 2019 Sep 8. doi: 10.1111/tbj.13569. [Epub ahead of print] No abstract available.

PMID:
31495033
3.

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review.

Boussios S, Karihtala P, Moschetta M, Karathanasi A, Sadauskaite A, Rassy E, Pavlidis N.

Diagnostics (Basel). 2019 Aug 1;9(3). pii: E87. doi: 10.3390/diagnostics9030087. Review.

4.

Prospective analysis of 895 patients on a UK Genomics Review Board.

Moore DA, Kushnir M, Mak G, Winter H, Curiel T, Voskoboynik M, Moschetta M, Rozumna-Martynyuk N, Balbi K, Bennett P, Forster M, Kulkarni A, Haynes D, Swanton C, Arkenau HT.

ESMO Open. 2019 Mar 21;4(2):e000469. doi: 10.1136/esmoopen-2018-000469. eCollection 2019.

5.

PARP Inhibitors in Ovarian Cancer: The Route to "Ithaca".

Boussios S, Karathanasi A, Cooke D, Neille C, Sadauskaite A, Moschetta M, Zakynthinakis-Kyriakou N, Pavlidis N.

Diagnostics (Basel). 2019 May 18;9(2). pii: E55. doi: 10.3390/diagnostics9020055. Review.

6.

Citron Rho-interacting kinase silencing causes cytokinesis failure and reduces tumor growth in multiple myeloma.

Sahin I, Kawano Y, Sklavenitis-Pistofidis R, Moschetta M, Mishima Y, Manier S, Sacco A, Carrasco R, Fonseca R, Roccaro AM, Witzig T, Ghobrial IM.

Blood Adv. 2019 Apr 9;3(7):995-1002. doi: 10.1182/bloodadvances.2018028456.

7.

Breast MRI background parenchymal enhancement as an imaging bridge to molecular cancer sub-type.

Dilorenzo G, Telegrafo M, La Forgia D, Stabile Ianora AA, Moschetta M.

Eur J Radiol. 2019 Apr;113:148-152. doi: 10.1016/j.ejrad.2019.02.018. Epub 2019 Feb 15.

PMID:
30927939
8.

BEECH: a dose-finding run-in followed by a randomised phase II study assessing the efficacy of AKT inhibitor capivasertib (AZD5363) combined with paclitaxel in patients with estrogen receptor-positive advanced or metastatic breast cancer, and in a PIK3CA mutant sub-population.

Turner NC, Alarcón E, Armstrong AC, Philco M, López Chuken YA, Sablin MP, Tamura K, Gómez Villanueva A, Pérez-Fidalgo JA, Cheung SYA, Corcoran C, Cullberg M, Davies BR, de Bruin EC, Foxley A, Lindemann JPO, Maudsley R, Moschetta M, Outhwaite E, Pass M, Rugman P, Schiavon G, Oliveira M.

Ann Oncol. 2019 May 1;30(5):774-780. doi: 10.1093/annonc/mdz086.

9.

Amyand's hernia: role of CT for a correct diagnosis.

Drago A, Carbone M, Lorusso V, Moschetta M, Scardapane A, Lucarelli N, Angelelli G, Stabile Ianora AA.

G Chir. 2019 Jan-Feb;40(1):44-48.

PMID:
30771798
10.

The Developing Story of Predictive Biomarkers in Colorectal Cancer.

Boussios S, Ozturk MA, Moschetta M, Karathanasi A, Zakynthinakis-Kyriakou N, Katsanos KH, Christodoulou DK, Pavlidis N.

J Pers Med. 2019 Feb 7;9(1). pii: E12. doi: 10.3390/jpm9010012. Review.

11.

Evaluation of Angiogenesis Process after Metformin and LY294002 Treatment in Mammary Tumor.

Moschetta MG, Leonel C, Maschio-Signorini LB, Borin TF, Gelaleti GB, Jardim-Perassi BV, Ferreira LC, Sonehara NM, Carvalho LGS, Hellmén E, de Campos Zuccari DAP.

Anticancer Agents Med Chem. 2019;19(5):655-666. doi: 10.2174/1871520619666181218164050.

PMID:
30569877
12.

Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives.

Boussios S, Moschetta M, Karathanasi A, Tsiouris AK, Kanellos FS, Tatsi K, Katsanos KH, Christodoulou DK.

Ann Gastroenterol. 2018 Nov-Dec;31(6):659-669. doi: 10.20524/aog.2018.0305. Epub 2018 Sep 14. Review.

13.

The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons.

Finelli MJ, Aprile D, Castroflorio E, Jeans A, Moschetta M, Chessum L, Degiacomi MT, Grasegger J, Lupien-Meilleur A, Bassett A, Rossignol E, Campeau PM, Bowl MR, Benfenati F, Fassio A, Oliver PL.

Hum Mol Genet. 2019 Feb 15;28(4):584-597. doi: 10.1093/hmg/ddy370.

14.

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives.

Boussios S, Moschetta M, Tatsi K, Tsiouris AK, Pavlidis N.

J Adv Res. 2018 Mar 6;12:1-9. doi: 10.1016/j.jare.2018.02.006. eCollection 2018 Jul. Review.

15.

Primary melanoma of the testis: myth.

Fortarezza F, Trabucco SMR, De Luisi A, Resta N, Cimmino A, Marzullo A, Moschetta M, Lettini T, Serio G.

Ann Transl Med. 2018 Apr;6(7):135. doi: 10.21037/atm.2018.02.14. No abstract available.

16.

Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab.

Kurdi AT, Glavey SV, Bezman NA, Jhatakia A, Guerriero JL, Manier S, Moschetta M, Mishima Y, Roccaro A, Detappe A, Liu CJ, Sacco A, Huynh D, Tai YT, Robbins MD, Azzi J, Ghobrial IM.

Mol Cancer Ther. 2018 Jul;17(7):1454-1463. doi: 10.1158/1535-7163.MCT-17-0998. Epub 2018 Apr 13.

17.

Blocking IFNAR1 inhibits multiple myeloma-driven Treg expansion and immunosuppression.

Kawano Y, Zavidij O, Park J, Moschetta M, Kokubun K, Mouhieddine TH, Manier S, Mishima Y, Murakami N, Bustoros M, Pistofidis RS, Reidy M, Shen YJ, Rahmat M, Lukyanchykov P, Karreci ES, Tsukamoto S, Shi J, Takagi S, Huynh D, Sacco A, Tai YT, Chesi M, Bergsagel PL, Roccaro AM, Azzi J, Ghobrial IM.

J Clin Invest. 2018 Jun 1;128(6):2487-2499. doi: 10.1172/JCI88169. Epub 2018 May 14.

18.

Lipoma of the transverse colon covered by tubulovillous adenoma: a rare indication for surgical treatment.

Moschetta M, Virelli R, Laricchia F, Alberotanza V, Telegrafo M, Angelelli G, Stabile Ianora AA.

G Chir. 2018 Jan-Feb;39(1):63-66.

19.

Towards an optimal treatment algorithm for metastatic pancreatic ductal adenocarcinoma (PDA).

Uccello M, Moschetta M, Mak G, Alam T, Henriquez CM, Arkenau HT.

Curr Oncol. 2018 Feb;25(1):e90-e94. doi: 10.3747/co.25.3708. Epub 2018 Feb 28. Review.

20.

Platelets Enhance Multiple Myeloma Progression via IL-1β Upregulation.

Takagi S, Tsukamoto S, Park J, Johnson KE, Kawano Y, Moschetta M, Liu CJ, Mishima Y, Kokubun K, Manier S, Salem KZ, Huynh D, Sacco A, Forward J, Roccaro AM, Battinelli EM, Ghobrial IM.

Clin Cancer Res. 2018 May 15;24(10):2430-2439. doi: 10.1158/1078-0432.CCR-17-2003. Epub 2018 Feb 9.

21.

Melatonin Differentially Modulates NF-кB Expression in Breast and Liver Cancer Cells.

Colombo J, Jardim-Perassi BV, Ferreira JPS, Braga CZ, Sonehara NM, Júnior RP, Moschetta MG, Girol AP, Zuccari DAPC.

Anticancer Agents Med Chem. 2018;18(12):1688-1694. doi: 10.2174/1871520618666180131112304.

PMID:
29384062
22.

Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade.

Moschetta M, Uccello M, Kasenda B, Mak G, McClelland A, Boussios S, Forster M, Arkenau HT.

Biomed Res Int. 2017;2017:1506824. doi: 10.1155/2017/1506824. Epub 2017 Nov 28.

23.

Reversible pneumatosis cystoides intestinalis after liver transplantation.

Telegrafo M, Stabile Ianora AA, Angelelli G, Moschetta M.

G Chir. 2017 Sep-Oct;38(5):239-242.

24.

Ovarian sex-cord stromal tumours and small cell tumours: Pathological, genetic and management aspects.

Boussios S, Moschetta M, Zarkavelis G, Papadaki A, Kefas A, Tatsi K.

Crit Rev Oncol Hematol. 2017 Dec;120:43-51. doi: 10.1016/j.critrevonc.2017.10.007. Epub 2017 Oct 16. Review.

PMID:
29198337
25.

Metformin Affects Cortical Bone Mass and Marrow Adiposity in Diet-Induced Obesity in Male Mice.

Bornstein S, Moschetta M, Kawano Y, Sacco A, Huynh D, Brooks D, Manier S, Fairfield H, Falank C, Roccaro AM, Nagano K, Baron R, Bouxein M, Vary C, Ghobrial IM, Rosen CJ, Reagan MR.

Endocrinology. 2017 Oct 1;158(10):3369-3385. doi: 10.1210/en.2017-00299.

26.

Bone Marrow Stroma and Vascular Contributions to Myeloma Bone Homing.

Moschetta M, Kawano Y, Sacco A, Belotti A, Ribolla R, Chiarini M, Giustini V, Bertoli D, Sottini A, Valotti M, Ghidini C, Serana F, Malagola M, Imberti L, Russo D, Montanelli A, Rossi G, Reagan MR, Maiso P, Paiva B, Ghobrial IM, Roccaro AM.

Curr Osteoporos Rep. 2017 Oct;15(5):499-506. doi: 10.1007/s11914-017-0399-3. Review.

PMID:
28889371
27.

Comparison between CT Net enhancement and PET/CT SUV for N staging of gastric cancer: A case series.

Stabile Ianora AA, Telegrafo M, Lucarelli NM, Lorusso V, Scardapane A, Niccoli Asabella A, Moschetta M.

Ann Med Surg (Lond). 2017 Jul 15;21:1-6. doi: 10.1016/j.amsu.2017.07.033. eCollection 2017 Sep.

28.

Efficacy of melatonin, IL-25 and siIL-17B in tumorigenesis-associated properties of breast cancer cell lines.

Gelaleti GB, Borin TF, Maschio-Signorini LB, Moschetta MG, Jardim-Perassi BV, Calvinho GB, Facchini MC, Viloria-Petit AM, de Campos Zuccari DAP.

Life Sci. 2017 Aug 15;183:98-109. doi: 10.1016/j.lfs.2017.06.013. Epub 2017 Jun 15.

PMID:
28624391
29.

A novel in vivo model for studying conditional dual loss of BLIMP-1 and p53 in B-cells, leading to tumor transformation.

Sacco A, Kawano Y, Moschetta M, Zavidij O, Huynh D, Reagan M, Mishima Y, Manier S, Park J, Morgan E, Takagi S, Wong KK, Carrasco R, Ghobrial IM, Roccaro AM.

Am J Hematol. 2017 Aug;92(8):E138-E145. doi: 10.1002/ajh.24778. Epub 2017 Jun 15.

30.

Endocavitary sonography of early oral cavity malignant tumors.

Angelelli G, Moschetta M, Limongelli L, Albergo A, Lacalendola E, Brindicci F, Favia G, Maiorano E.

Head Neck. 2017 Jul;39(7):1349-1356. doi: 10.1002/hed.24779. Epub 2017 Mar 29.

PMID:
28370753
31.

Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.

Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer ME, Asara JM, Palumbo A, Roccaro AM, Hynes RO, Ghobrial IM.

Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27.

PMID:
28344315
32.

Melatonin and IL-25 modulate apoptosis and angiogenesis mediators in metastatic (CF-41) and non-metastatic (CMT-U229) canine mammary tumour cells.

Gelaleti GB, Borin TF, Maschio-Signorini LB, Moschetta MG, Hellmén E, Viloria-Petit AM, Zuccari DAPC.

Vet Comp Oncol. 2017 Dec;15(4):1572-1584. doi: 10.1111/vco.12303. Epub 2017 Mar 20.

PMID:
28322030
33.

Second-Line Combination Therapies in Pancreatic Cancer: Where Are We Now?

Uccello M, Moschetta M, Arkenau HT.

J Clin Oncol. 2017 Apr 20;35(12):1370-1371. doi: 10.1200/JCO.2016.71.0921. Epub 2017 Jan 23. No abstract available.

PMID:
28113022
34.

Follow-up of multicentric HCC according to the mRECIST criteria: role of 320-Row CT with semi-automatic 3D analysis software for evaluating the response to systemic therapy.

Telegrafo M, Dilorenzo G, Di Giovanni G, Cornacchia I, Stabile Ianora AA, Cornacchia I, Stabile Ianora AA, Angelelli G, Moschetta M.

G Chir. 2017 Sep-Oct;37(5):206-210.

35.

Inhibition of Epithelial-Mesenchymal Transition and Metastasis by Combined TGFbeta Knockdown and Metformin Treatment in a Canine Mammary Cancer Xenograft Model.

Leonel C, Borin TF, de Carvalho Ferreira L, Moschetta MG, Bajgelman MC, Viloria-Petit AM, de Campos Zuccari DA.

J Mammary Gland Biol Neoplasia. 2017 Mar;22(1):27-41. doi: 10.1007/s10911-016-9370-7. Epub 2017 Jan 11.

PMID:
28078601
36.

Dabrafenib and trametinib activity in a patient with BRAF V600E mutated and microsatellite instability high (MSI-H) metastatic endometrial cancer.

Moschetta M, Mak G, Hauser J, Davies C, Uccello M, Arkenau HT.

Exp Hematol Oncol. 2017 Jan 10;6:1. doi: 10.1186/s40164-016-0061-2. eCollection 2017.

37.

Inhibition of Epithelial-mesenchymal Transition in Response to Treatment with Metformin and Y27632 in Breast Cancer Cell Lines.

Leonel C, Ferreira LC, Borin TF, Moschetta MG, Freitas GS, Haddad MR, de Camargos Pinto Robles JA, Aparecida Pires de Campos Zuccari D.

Anticancer Agents Med Chem. 2017;17(8):1113-1125. doi: 10.2174/1871520617666170102153954.

PMID:
28042775
38.

Exosomes in Tumor Angiogenesis.

Salem KZ, Moschetta M, Sacco A, Imberti L, Rossi G, Ghobrial IM, Manier S, Roccaro AM.

Methods Mol Biol. 2016;1464:25-34.

PMID:
27858353
39.

The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma.

Manier S, Powers JT, Sacco A, Glavey SV, Huynh D, Reagan MR, Salem KZ, Moschetta M, Shi J, Mishima Y, Roche-Lestienne C, Leleu X, Roccaro AM, Daley GQ, Ghobrial IM.

Leukemia. 2017 Apr;31(4):853-860. doi: 10.1038/leu.2016.296. Epub 2016 Oct 24.

40.

Correction: Sunitinib prevents cachexia and prolongs survival of mice bearing renal cancer by restraining STAT3 and MuRF-1 activation in muscle.

Pretto F, Ghilardi C, Moschetta M, Bassi A, Rovida A, Scarlato V, Talamini L, Fiordaliso F, Bisighini C, Damia G, Bani MR, Piccirillo R, Giavazzi R.

Oncotarget. 2016 Jun 21;7(25):38973. doi: 10.18632/oncotarget.9971. No abstract available.

41.

Uremic lung: The "calcified cauliflower" sign in the end stage renal disease.

Dilorenzo G, Telegrafo M, Marano G, De Ceglie M, Stabile Ianora AA, Angelelli G, Moschetta M.

Respir Med Case Rep. 2016 Oct 6;19:159-161. eCollection 2016.

42.

Prognostic value of Tissue Transition Projection 3D transparent wall CT reconstructions in bowel ischemia.

Moschetta M, Scardapane A, Telegrafo M, Lucarelli NM, Lorusso V, Angelelli G, Stabile Ianora AA.

Int J Surg. 2016 Oct;34:137-141. doi: 10.1016/j.ijsu.2016.08.525. Epub 2016 Aug 31.

43.

Breast US as primary imaging modality for diagnosing gynecomastia.

Telegrafo M, Introna T, Coi L, Cornacchia I, Rella L, Stabile Ianora AA, Angelelli G, Moschetta M.

G Chir. 2016 May-Jun;37(3):118-122.

44.

Targeting the Bone Marrow Microenvironment.

Moschetta M, Kawano Y, Podar K.

Cancer Treat Res. 2016;169:63-102. Review.

PMID:
27696259
45.

Diagnostic and prognostic role of computed tomography in extracorporeal shock wave lithotripsy complications.

Telegrafo M, Carluccio DA, Rella L, Ianora AA, Angelelli G, Moschetta M.

Urol Ann. 2016 Apr-Jun;8(2):168-72. doi: 10.4103/0974-7796.163792.

46.

APRIL and BCMA promote human multiple myeloma growth and immunosuppression in the bone marrow microenvironment.

Tai YT, Acharya C, An G, Moschetta M, Zhong MY, Feng X, Cea M, Cagnetta A, Wen K, van Eenennaam H, van Elsas A, Qiu L, Richardson P, Munshi N, Anderson KC.

Blood. 2016 Jun 23;127(25):3225-36. doi: 10.1182/blood-2016-01-691162. Epub 2016 Apr 28.

47.

Abbreviated Combined MR Protocol: A New Faster Strategy for Characterizing Breast Lesions.

Moschetta M, Telegrafo M, Rella L, Stabile Ianora AA, Angelelli G.

Clin Breast Cancer. 2016 Jun;16(3):207-11. doi: 10.1016/j.clbc.2016.02.008. Epub 2016 Feb 11.

PMID:
27108218
48.

Melatonin Regulates Angiogenic and Inflammatory Proteins in MDA-MB-231 Cell Line and in Co-culture with Cancer-associated Fibroblasts.

Maschio-Signorini LB, Gelaleti GB, Moschetta MG, Borin TF, Jardim-Perassi BV, Lopes JR, Lacerda JZ, Roela RA, Bordin NA, Corrêa LA, Cardoso JP, Zuccari DA.

Anticancer Agents Med Chem. 2016;16(11):1474-1484.

PMID:
27102277
49.

BRCA somatic mutations and epigenetic BRCA modifications in serous ovarian cancer.

Moschetta M, George A, Kaye SB, Banerjee S.

Ann Oncol. 2016 Aug;27(8):1449-55. doi: 10.1093/annonc/mdw142. Epub 2016 Mar 31. Review.

PMID:
27037296
50.

Proinflammatory and Anti-Inflammatory Cytokines Mediated by NF-κB Factor as Prognostic Markers in Mammary Tumors.

Martins GR, Gelaleti GB, Moschetta MG, Maschio-Signorini LB, Zuccari DA.

Mediators Inflamm. 2016;2016:9512743. doi: 10.1155/2016/9512743. Epub 2016 Feb 16.

Supplemental Content

Loading ...
Support Center